1 Study Coverage 1.1 Diabetic Lancing Device Product Introduction 1.2 Global Diabetic Lancing Device Outlook 2017 VS 2022 VS 2028 1.2.1 Global Diabetic Lancing Device Sales in US$ Million for the Year 2017-2028 1.2.2 Global Diabetic Lancing Device Sales in Volume for the Year 2017-2028 1.3 United States Diabetic Lancing Device Outlook 2017 VS 2022 VS 2028 1.3.1 United States Diabetic Lancing Device Sales in US$ Million for the Year 2017-2028 1.3.2 United States Diabetic Lancing Device Sales in Volume for the Year 2017-2028 1.4 Diabetic Lancing Device Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4.1 The Market Share of United States Diabetic Lancing Device in Global, 2017 VS 2022 VS 2028 1.4.2 The Growth Rate of Diabetic Lancing Device Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.5 Diabetic Lancing Device Market Dynamics 1.5.1 Diabetic Lancing Device Industry Trends 1.5.2 Diabetic Lancing Device Market Drivers 1.5.3 Diabetic Lancing Device Market Challenges 1.5.4 Diabetic Lancing Device Market Restraints 1.6 Study Objectives 1.7 Years Considered 2 Market by Type 2.1 Diabetic Lancing Device Market Segment by Type 2.1.1 Push Button Safety Lancets 2.1.2 Pressure Activated Safety Lancets 2.1.3 Side Button Safety Lancets 2.2 Global Diabetic Lancing Device Market Size by Type 2.2.1 Global Diabetic Lancing Device Sales in Value, by Type (2017, 2022 & 2028) 2.2.2 Global Diabetic Lancing Device Sales in Volume, by Type (2017, 2022 & 2028) 2.2.3 Global Diabetic Lancing Device Average Selling Price (ASP) by Type (2017, 2022 & 2028) 2.3 United States Diabetic Lancing Device Market Size by Type 2.3.1 United States Diabetic Lancing Device Sales in Value, by Type (2017, 2022 & 2028) 2.3.2 United States Diabetic Lancing Device Sales in Volume, by Type (2017, 2022 & 2028) 2.3.3 United States Diabetic Lancing Device Average Selling Price (ASP) by Type (2017, 2022 & 2028) 3 Market by Application 3.1 Diabetic Lancing Device Market Segment by Application 3.1.1 Hospitals 3.1.2 Clinics 3.2 Global Diabetic Lancing Device Market Size by Application 3.2.1 Global Diabetic Lancing Device Sales in Value, by Application (2017, 2022 & 2028) 3.2.2 Global Diabetic Lancing Device Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 Global Diabetic Lancing Device Average Selling Price (ASP) by Application (2017, 2022 & 2028) 3.3 United States Diabetic Lancing Device Market Size by Application 3.3.1 United States Diabetic Lancing Device Sales in Value, by Application (2017, 2022 & 2028) 3.3.2 United States Diabetic Lancing Device Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 United States Diabetic Lancing Device Average Selling Price (ASP) by Application (2017, 2022 & 2028) 4 Global Diabetic Lancing Device Competitor Landscape by Company 4.1 Global Diabetic Lancing Device Market Size by Company 4.1.1 Top Global Diabetic Lancing Device Manufacturers Ranked by Revenue (2021) 4.1.2 Global Diabetic Lancing Device Revenue by Manufacturer (2017-2022) 4.1.3 Global Diabetic Lancing Device Sales by Manufacturer (2017-2022) 4.1.4 Global Diabetic Lancing Device Price by Manufacturer (2017-2022) 4.2 Global Diabetic Lancing Device Concentration Ratio (CR) 4.2.1 Diabetic Lancing Device Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Diabetic Lancing Device in 2021 4.2.3 Global Diabetic Lancing Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Diabetic Lancing Device Manufacturing Base Distribution, Product Type 4.3.1 Global Diabetic Lancing Device Manufacturers, Headquarters and Distribution of Producing Region 4.3.2 Manufacturers Diabetic Lancing Device Product Type 4.3.3 Date of International Manufacturers Enter into Diabetic Lancing Device Market 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans 4.5 United States Diabetic Lancing Device Market Size by Company 4.5.1 Top Diabetic Lancing Device Players in United States, Ranked by Revenue (2021) 4.5.2 United States Diabetic Lancing Device Revenue by Players (2020, 2021 & 2022) 4.5.3 United States Diabetic Lancing Device Sales by Players (2020, 2021 & 2022) 5 Global Diabetic Lancing Device Market Size by Region 5.1 Global Diabetic Lancing Device Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Diabetic Lancing Device Market Size in Volume by Region (2017-2028) 5.2.1 Global Diabetic Lancing Device Sales in Volume by Region: 2017-2022 5.2.2 Global Diabetic Lancing Device Sales in Volume Forecast by Region (2023-2028) 5.3 Global Diabetic Lancing Device Market Size in Value by Region (2017-2028) 5.3.1 Global Diabetic Lancing Device Sales in Value by Region: 2017-2022 5.3.2 Global Diabetic Lancing Device Sales in Value by Region: 2023-2028 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Diabetic Lancing Device Market Size YoY Growth 2017-2028 6.1.2 North America Diabetic Lancing Device Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Diabetic Lancing Device Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Diabetic Lancing Device Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Diabetic Lancing Device Market Size YoY Growth 2017-2028 6.3.2 Europe Diabetic Lancing Device Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Diabetic Lancing Device Market Size YoY Growth 2017-2028 6.4.2 Latin America Diabetic Lancing Device Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Diabetic Lancing Device Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Diabetic Lancing Device Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 U.A.E 7 Company Profiles 7.1 B. Braun 7.1.1 B. Braun Corporation Information 7.1.2 B. Braun Description and Business Overview 7.1.3 B. Braun Diabetic Lancing Device Sales, Revenue and Gross Margin (2017-2022) 7.1.4 B. Braun Diabetic Lancing Device Products Offered 7.1.5 B. Braun Recent Development 7.2 Terumo Corporation 7.2.1 Terumo Corporation Corporation Information 7.2.2 Terumo Corporation Description and Business Overview 7.2.3 Terumo Corporation Diabetic Lancing Device Sales, Revenue and Gross Margin (2017-2022) 7.2.4 Terumo Corporation Diabetic Lancing Device Products Offered 7.2.5 Terumo Corporation Recent Development 7.3 Becton Dickinson 7.3.1 Becton Dickinson Corporation Information 7.3.2 Becton Dickinson Description and Business Overview 7.3.3 Becton Dickinson Diabetic Lancing Device Sales, Revenue and Gross Margin (2017-2022) 7.3.4 Becton Dickinson Diabetic Lancing Device Products Offered 7.3.5 Becton Dickinson Recent Development 7.4 Sanofi 7.4.1 Sanofi Corporation Information 7.4.2 Sanofi Description and Business Overview 7.4.3 Sanofi Diabetic Lancing Device Sales, Revenue and Gross Margin (2017-2022) 7.4.4 Sanofi Diabetic Lancing Device Products Offered 7.4.5 Sanofi Recent Development 7.5 Roche 7.5.1 Roche Corporation Information 7.5.2 Roche Description and Business Overview 7.5.3 Roche Diabetic Lancing Device Sales, Revenue and Gross Margin (2017-2022) 7.5.4 Roche Diabetic Lancing Device Products Offered 7.5.5 Roche Recent Development 7.6 Bayer 7.6.1 Bayer Corporation Information 7.6.2 Bayer Description and Business Overview 7.6.3 Bayer Diabetic Lancing Device Sales, Revenue and Gross Margin (2017-2022) 7.6.4 Bayer Diabetic Lancing Device Products Offered 7.6.5 Bayer Recent Development 7.7 Novo Nordisk 7.7.1 Novo Nordisk Corporation Information 7.7.2 Novo Nordisk Description and Business Overview 7.7.3 Novo Nordisk Diabetic Lancing Device Sales, Revenue and Gross Margin (2017-2022) 7.7.4 Novo Nordisk Diabetic Lancing Device Products Offered 7.7.5 Novo Nordisk Recent Development 7.8 Eli Lilly 7.8.1 Eli Lilly Corporation Information 7.8.2 Eli Lilly Description and Business Overview 7.8.3 Eli Lilly Diabetic Lancing Device Sales, Revenue and Gross Margin (2017-2022) 7.8.4 Eli Lilly Diabetic Lancing Device Products Offered 7.8.5 Eli Lilly Recent Development 7.9 Medtronic 7.9.1 Medtronic Corporation Information 7.9.2 Medtronic Description and Business Overview 7.9.3 Medtronic Diabetic Lancing Device Sales, Revenue and Gross Margin (2017-2022) 7.9.4 Medtronic Diabetic Lancing Device Products Offered 7.9.5 Medtronic Recent Development 7.10 Ypsomed Holding 7.10.1 Ypsomed Holding Corporation Information 7.10.2 Ypsomed Holding Description and Business Overview 7.10.3 Ypsomed Holding Diabetic Lancing Device Sales, Revenue and Gross Margin (2017-2022) 7.10.4 Ypsomed Holding Diabetic Lancing Device Products Offered 7.10.5 Ypsomed Holding Recent Development 7.11 Sarstedt 7.11.1 Sarstedt Corporation Information 7.11.2 Sarstedt Description and Business Overview 7.11.3 Sarstedt Diabetic Lancing Device Sales, Revenue and Gross Margin (2017-2022) 7.11.4 Sarstedt Diabetic Lancing Device Products Offered 7.11.5 Sarstedt Recent Development 7.12 Abbott Laboratories 7.12.1 Abbott Laboratories Corporation Information 7.12.2 Abbott Laboratories Description and Business Overview 7.12.3 Abbott Laboratories Diabetic Lancing Device Sales, Revenue and Gross Margin (2017-2022) 7.12.4 Abbott Laboratories Products Offered 7.12.5 Abbott Laboratories Recent Development 7.13 HTL-STREFA 7.13.1 HTL-STREFA Corporation Information 7.13.2 HTL-STREFA Description and Business Overview 7.13.3 HTL-STREFA Diabetic Lancing Device Sales, Revenue and Gross Margin (2017-2022) 7.13.4 HTL-STREFA Products Offered 7.13.5 HTL-STREFA Recent Development 7.14 Improve Medical 7.14.1 Improve Medical Corporation Information 7.14.2 Improve Medical Description and Business Overview 7.14.3 Improve Medical Diabetic Lancing Device Sales, Revenue and Gross Margin (2017-2022) 7.14.4 Improve Medical Products Offered 7.14.5 Improve Medical Recent Development 7.15 UltiMed 7.15.1 UltiMed Corporation Information 7.15.2 UltiMed Description and Business Overview 7.15.3 UltiMed Diabetic Lancing Device Sales, Revenue and Gross Margin (2017-2022) 7.15.4 UltiMed Products Offered 7.15.5 UltiMed Recent Development 7.16 Allison Medical 7.16.1 Allison Medical Corporation Information 7.16.2 Allison Medical Description and Business Overview 7.16.3 Allison Medical Diabetic Lancing Device Sales, Revenue and Gross Margin (2017-2022) 7.16.4 Allison Medical Products Offered 7.16.5 Allison Medical Recent Development 7.17 Artsana 7.17.1 Artsana Corporation Information 7.17.2 Artsana Description and Business Overview 7.17.3 Artsana Diabetic Lancing Device Sales, Revenue and Gross Margin (2017-2022) 7.17.4 Artsana Products Offered 7.17.5 Artsana Recent Development 8 Industry Chain and Sales Channels Analysis 8.1 Diabetic Lancing Device Industry Chain Analysis 8.2 Diabetic Lancing Device Key Raw Materials 8.2.1 Key Raw Materials 8.2.2 Diabetic Lancing Device Distributors 8.3 Diabetic Lancing Device Production Mode & Process 8.4 Diabetic Lancing Device Sales and Marketing 8.4.1 Diabetic Lancing Device Sales Channels 8.4.2 Diabetic Lancing Device Distributors 8.5 Diabetic Lancing Device Customers 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer

List of Tables Table 1. Diabetic Lancing Device CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028 Table 2. Diabetic Lancing Device Market Trends Table 3. Diabetic Lancing Device Market Drivers Table 4. Diabetic Lancing Device Market Challenges Table 5. Diabetic Lancing Device Market Restraints Table 6. Global Diabetic Lancing Device Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Diabetic Lancing Device Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Diabetic Lancing Device Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Diabetic Lancing Device Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Diabetic Lancing Device Manufacturers in Global Market, Ranking by Revenue (2021) Table 11. Global Diabetic Lancing Device Revenue by Manufacturer, (US$ Million), 2017-2022 Table 12. Global Diabetic Lancing Device Revenue Share by Manufacturer, 2017-2022 Table 13. Global Diabetic Lancing Device Sales by Manufacturer, (K Units), 2017-2022 Table 14. Global Diabetic Lancing Device Sales Share by Manufacturer, 2017-2022 Table 15. Global Diabetic Lancing Device Price by Manufacturer (2017-2022) & (USD/Unit) Table 16. Global Diabetic Lancing Device Manufacturers Market Concentration Ratio (CR5 and HHI) Table 17. Global Diabetic Lancing Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetic Lancing Device as of 2021) Table 18. Top Players of Diabetic Lancing Device in Global Market, Headquarters and Distribution of Producing Region Table 19. Manufacturers Diabetic Lancing Device Product Type Table 20. Date of International Manufacturers Enter into Diabetic Lancing Device Market Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans Table 22. Top Diabetic Lancing Device Players in United States Market, Ranking by Revenue (2021) Table 23. United States Diabetic Lancing Device Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 24. United States Diabetic Lancing Device Revenue Share by Players, 2020, 2021 & 2022 Table 25. United States Diabetic Lancing Device Sales by Players, (K Units), 2020, 2021 & 2022 Table 26. United States Diabetic Lancing Device Sales Share by Players, 2020, 2021 & 2022 Table 27. Global Diabetic Lancing Device Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 28. Global Diabetic Lancing Device Sales in Volume by Region (2017-2022) & (K Units) Table 29. Global Diabetic Lancing Device Sales in Volume Forecast by Region (2023-2028) & (K Units) Table 30. Global Diabetic Lancing Device Sales in Value by Region (2017-2022) & (US$ Million) Table 31. Global Diabetic Lancing Device Sales in Value Forecast by Region (2023-2028) & (US$ Million) Table 32. North America Diabetic Lancing Device Sales in Volume by Country (2017-2028) & (K Units) Table 33. North America Diabetic Lancing Device Sales in Value by Country (2017-2028) & (US$ Million) Table 34. Asia Pacific Diabetic Lancing Device Sales in Volume by Region (2017-2028) & (K Units) Table 35. Asia Pacific Diabetic Lancing Device Sales in Value by Region (2017-2028) & (US$ Million) Table 36. Europe Diabetic Lancing Device Sales in Volume by Country (2017-2028) & (K Units) Table 37. Europe Diabetic Lancing Device Sales in Value by Country (2017-2028) & (US$ Million) Table 38. Latin America Diabetic Lancing Device Sales in Volume by Country (2017-2028) & (K Units) Table 39. Latin Americaa Diabetic Lancing Device Sales in Value by Country (2017-2028) & (US$ Million) Table 40. Middle East and Africa Diabetic Lancing Device Sales in Volume by Country (2017-2028) & (K Units) Table 41. Middle East and Africa Diabetic Lancing Device Sales in Value by Country (2017-2028) & (US$ Million) Table 42. B. Braun Corporation Information Table 43. B. Braun Description and Business Overview Table 44. B. Braun Diabetic Lancing Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 45. B. Braun Diabetic Lancing Device Product Table 46. B. Braun Recent Development Table 47. Terumo Corporation Corporation Information Table 48. Terumo Corporation Description and Business Overview Table 49. Terumo Corporation Diabetic Lancing Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 50. Terumo Corporation Product Table 51. Terumo Corporation Recent Development Table 52. Becton Dickinson Corporation Information Table 53. Becton Dickinson Description and Business Overview Table 54. Becton Dickinson Diabetic Lancing Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 55. Becton Dickinson Product Table 56. Becton Dickinson Recent Development Table 57. Sanofi Corporation Information Table 58. Sanofi Description and Business Overview Table 59. Sanofi Diabetic Lancing Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 60. Sanofi Product Table 61. Sanofi Recent Development Table 62. Roche Corporation Information Table 63. Roche Description and Business Overview Table 64. Roche Diabetic Lancing Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 65. Roche Product Table 66. Roche Recent Development Table 67. Bayer Corporation Information Table 68. Bayer Description and Business Overview Table 69. Bayer Diabetic Lancing Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 70. Bayer Product Table 71. Bayer Recent Development Table 72. Novo Nordisk Corporation Information Table 73. Novo Nordisk Description and Business Overview Table 74. Novo Nordisk Diabetic Lancing Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 75. Novo Nordisk Product Table 76. Novo Nordisk Recent Development Table 77. Eli Lilly Corporation Information Table 78. Eli Lilly Description and Business Overview Table 79. Eli Lilly Diabetic Lancing Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 80. Eli Lilly Product Table 81. Eli Lilly Recent Development Table 82. Medtronic Corporation Information Table 83. Medtronic Description and Business Overview Table 84. Medtronic Diabetic Lancing Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 85. Medtronic Product Table 86. Medtronic Recent Development Table 87. Ypsomed Holding Corporation Information Table 88. Ypsomed Holding Description and Business Overview Table 89. Ypsomed Holding Diabetic Lancing Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 90. Ypsomed Holding Product Table 91. Ypsomed Holding Recent Development Table 92. Sarstedt Corporation Information Table 93. Sarstedt Description and Business Overview Table 94. Sarstedt Diabetic Lancing Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 95. Sarstedt Product Table 96. Sarstedt Recent Development Table 97. Abbott Laboratories Corporation Information Table 98. Abbott Laboratories Description and Business Overview Table 99. Abbott Laboratories Diabetic Lancing Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 100. Abbott Laboratories Product Table 101. Abbott Laboratories Recent Development Table 102. HTL-STREFA Corporation Information Table 103. HTL-STREFA Description and Business Overview Table 104. HTL-STREFA Diabetic Lancing Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 105. HTL-STREFA Product Table 106. HTL-STREFA Recent Development Table 107. Improve Medical Corporation Information Table 108. Improve Medical Description and Business Overview Table 109. Improve Medical Diabetic Lancing Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 110. Improve Medical Product Table 111. Improve Medical Recent Development Table 112. UltiMed Corporation Information Table 113. UltiMed Description and Business Overview Table 114. UltiMed Diabetic Lancing Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 115. UltiMed Product Table 116. UltiMed Recent Development Table 117. Allison Medical Corporation Information Table 118. Allison Medical Description and Business Overview Table 119. Allison Medical Diabetic Lancing Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 120. Allison Medical Product Table 121. Allison Medical Recent Development Table 122. Artsana Corporation Information Table 123. Artsana Description and Business Overview Table 124. Artsana Diabetic Lancing Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 125. Artsana Product Table 126. Artsana Recent Development Table 127. Key Raw Materials Lists Table 128. Raw Materials Key Suppliers Lists Table 129. Diabetic Lancing Device Customers List Table 130. Diabetic Lancing Device Distributors List Table 131. Research Programs/Design for This Report Table 132. Key Data Information from Secondary Sources Table 133. Key Data Information from Primary Sources List of Figures Figure 1. Diabetic Lancing Device Product Picture Figure 2. Global Diabetic Lancing Device Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Diabetic Lancing Device Market Size 2017-2028 (US$ Million) Figure 4. Global Diabetic Lancing Device Sales 2017-2028 (K Units) Figure 5. United States Diabetic Lancing Device Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 6. United States Diabetic Lancing Device Market Size 2017-2028 (US$ Million) Figure 7. United States Diabetic Lancing Device Sales 2017-2028 (K Units) Figure 8. United States Diabetic Lancing Device Market Share in Global, in Value (US$ Million) 2017-2028 Figure 9. United States Diabetic Lancing Device Market Share in Global, in Volume (K Units) 2017-2028 Figure 10. Diabetic Lancing Device Report Years Considered Figure 11. Product Picture of Push Button Safety Lancets Figure 12. Product Picture of Pressure Activated Safety Lancets Figure 13. Product Picture of Side Button Safety Lancets Figure 14. Global Diabetic Lancing Device Market Share by Type in 2022 & 2028 Figure 15. Global Diabetic Lancing Device Sales in Value by Type (2017-2028) & (US$ Million) Figure 16. Global Diabetic Lancing Device Sales Market Share in Value by Type (2017-2028) Figure 17. Global Diabetic Lancing Device Sales by Type (2017-2028) & (K Units) Figure 18. Global Diabetic Lancing Device Sales Market Share in Volume by Type (2017-2028) Figure 19. Global Diabetic Lancing Device Price by Type (2017-2028) & (USD/Unit) Figure 20. United States Diabetic Lancing Device Market Share by Type in 2022 & 2028 Figure 21. United States Diabetic Lancing Device Sales in Value by Type (2017-2028) & (US$ Million) Figure 22. United States Diabetic Lancing Device Sales Market Share in Value by Type (2017-2028) Figure 23. United States Diabetic Lancing Device Sales by Type (2017-2028) & (K Units) Figure 24. United States Diabetic Lancing Device Sales Market Share in Volume by Type (2017-2028) Figure 25. United States Diabetic Lancing Device Price by Type (2017-2028) & (USD/Unit) Figure 26. Product Picture of Hospitals Figure 27. Product Picture of Clinics Figure 28. Global Diabetic Lancing Device Market Share by Application in 2022 & 2028 Figure 29. Global Diabetic Lancing Device Sales in Value by Application (2017-2028) & (US$ Million) Figure 30. Global Diabetic Lancing Device Sales Market Share in Value by Application (2017-2028) Figure 31. Global Diabetic Lancing Device Sales by Application (2017-2028) & (K Units) Figure 32. Global Diabetic Lancing Device Sales Market Share in Volume by Application (2017-2028) Figure 33. Global Diabetic Lancing Device Price by Application (2017-2028) & (USD/Unit) Figure 34. United States Diabetic Lancing Device Market Share by Application in 2022 & 2028 Figure 35. United States Diabetic Lancing Device Sales in Value by Application (2017-2028) & (US$ Million) Figure 36. United States Diabetic Lancing Device Sales Market Share in Value by Application (2017-2028) Figure 37. United States Diabetic Lancing Device Sales by Application (2017-2028) & (K Units) Figure 38. United States Diabetic Lancing Device Sales Market Share in Volume by Application (2017-2028) Figure 39. United States Diabetic Lancing Device Price by Application (2017-2028) & (USD/Unit) Figure 40. North America Diabetic Lancing Device Sales in Volume Growth Rate 2017-2028 (K Units) Figure 41. North America Diabetic Lancing Device Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 42. U.S. Diabetic Lancing Device Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 43. Canada Diabetic Lancing Device Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 44. Europe Diabetic Lancing Device Sales in Volume Growth Rate 2017-2028 (K Units) Figure 45. Europe Diabetic Lancing Device Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 46. Germany Diabetic Lancing Device Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 47. France Diabetic Lancing Device Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 48. U.K. Diabetic Lancing Device Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 49. Italy Diabetic Lancing Device Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 50. Russia Diabetic Lancing Device Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 51. Asia-Pacific Diabetic Lancing Device Sales in Volume Growth Rate 2017-2028 (K Units) Figure 52. Asia-Pacific Diabetic Lancing Device Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 53. China Diabetic Lancing Device Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 54. Japan Diabetic Lancing Device Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 55. South Korea Diabetic Lancing Device Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 56. India Diabetic Lancing Device Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 57. Australia Diabetic Lancing Device Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 58. Taiwan Diabetic Lancing Device Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 59. Indonesia Diabetic Lancing Device Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 60. Thailand Diabetic Lancing Device Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 61. Malaysia Diabetic Lancing Device Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 62. Philippines Diabetic Lancing Device Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 63. Latin America Diabetic Lancing Device Sales in Volume Growth Rate 2017-2028 (K Units) Figure 64. Latin America Diabetic Lancing Device Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 65. Mexico Diabetic Lancing Device Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 66. Brazil Diabetic Lancing Device Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 67. Argentina Diabetic Lancing Device Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 68. Middle East & Africa Diabetic Lancing Device Sales in Volume Growth Rate 2017-2028 (K Units) Figure 69. Middle East & Africa Diabetic Lancing Device Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 70. Turkey Diabetic Lancing Device Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 71. Saudi Arabia Diabetic Lancing Device Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 72. U.A.E Diabetic Lancing Device Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 73. Diabetic Lancing Device Value Chain Figure 74. Diabetic Lancing Device Production Process Figure 75. Channels of Distribution Figure 76. Distributors Profiles Figure 77. Bottom-up and Top-down Approaches for This Report Figure 78. Data Triangulation Figure 79. Key Executives Interviewed

B. Braun Terumo Corporation Becton Dickinson Sanofi Roche Bayer Novo Nordisk Eli Lilly Medtronic Ypsomed Holding Sarstedt Abbott Laboratories HTL-STREFA Improve Medical UltiMed Allison Medical Artsana